Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

Abbott ABT has received the FDA’s investigational ... Physicians often use several therapy approaches to clear calcified arterial blockages, including cutting balloons and atherectomy technology.

March 27, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark in ... of electrophysiology across Europe and signals we're moving beyond early therapy approaches to new ...